Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes.
Eduardo A Yepez GuevaraSamuel L AitkenAdilene V OlveraLily CarlinKerri E FernandesMicah M BhattiKevin W GareyJavier AdachiPablo C OkhuysenPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
When compared to cancer patients with fecal NAAT+/EIA-, patients with NAAT+/EIA+ CDI are less likely to respond to therapy and more likely to experience recurrence, particularly when due to ribotypes associated with poor outcomes.